Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS

NCT05241067 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

DRUG: Normal Saline
DRUG: Centhaquine

Sponsor

Pharmazz, Inc.